Scientech Research LLC’s Ocugen OCGN Stock Holding History

Scientech Research LLC’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-188,525	Closed	-$341K	–	456
2026 Q1	$341K	Buy	+188,525	New	+$326K	0.28%	100
2025 Q4	–	Sell	-105,005	Closed	-$171K	–	720
2025 Q3	$171K	Buy	+105,005	New	+$116K	0.06%	484

Other funds holding OCGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Scientech Research LLC's OCGN Position: Q2 2026 in Review

Scientech Research LLC sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 188,525 shares — an estimated $341K sold.

Scientech Research LLC first reported a position in OCGN in Q3 2025 and held it in 2 quarters. The position peaked at $341K in Q1 2026. 148 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

Scientech Research LLC reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
Scientech Research LLC sold 188,525 Ocugen shares in Q2 2026, an estimated $341K.
Scientech Research LLC first reported a position in Ocugen in Q3 2025 and held it in 2 quarters.
Scientech Research LLC's Ocugen position peaked at $341K in Q1 2026.
148 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.